Galaxy Medicare (NSE:GML) Total Stockholders Equity: ₹403.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:GML Galaxy Medicare Ltd NSE:GML
20 GF Score
Price ₹17.10
! 2 Warning Signs
View Full Analysis

What is Galaxy Medicare Total Stockholders Equity?

Galaxy Medicare NSE:GML -0.29% 20 Total Stockholders Equity is ₹403.4 Mil as of Mar. 2026. GuruFocus rates NSE:GML with a GF Score™ of 20/100. The stock has 2 warning signs investors should review.

Galaxy Medicare's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹403.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Galaxy Medicare's Book Value per Share for the quarter that ended in Mar. 2026 was ₹26.54. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Galaxy Medicare's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.10.


Galaxy Medicare  (NSE:GML) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Galaxy Medicare's Book Value per Share for the quarter that ended in Mar. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Galaxy Medicare's Debt-to-Equity for the quarter that ended in Mar. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galaxy Medicare Total Stockholders Equity Related Terms


Galaxy Medicare Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Galaxy Medicare's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galaxy Medicare Total Stockholders Equity Chart

Galaxy Medicare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
164.03 178.22 213.77 241.55 403.39

Galaxy Medicare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial 213.77 230.87 241.55 394.72 403.39
NSE:GML
20GF Score
Galaxy Medicare Ltd NSE:GML
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₹403.4 Mil mean?
Galaxy Medicare (NSE:GML) has a Total Stockholders Equity of ₹403.4 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Galaxy Medicare and its competitors.
Is Galaxy Medicare's Total Stockholders Equity too high?
Galaxy Medicare's current Total Stockholders Equity is ₹403.4 Mil. Overall, Galaxy Medicare has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's Total Stockholders Equity compare to ISRG and BDX?
Galaxy Medicare's Total Stockholders Equity of ₹403.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Galaxy Medicare and its competitors. Galaxy Medicare's current Total Stockholders Equity is ₹403.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current Total Stockholders Equity of ₹403.4 Mil. The current Total Stockholders Equity is ₹403.4 Mil. Galaxy Medicare's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current Total Stockholders Equity is ₹403.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galaxy Medicare Business Description

Address Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate, Khurda, Bhubaneswar, OR, IND, 751010
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
20GF Score

Get the complete analysis for NSE:GML

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹17.10
Price